Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Experimental Mammary Neoplasms

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Experimental Mammary Neoplasms in 2 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research Excerpts

ExcerptRelevanceReference
"In YC-1-treated breast cancer cells and tumour specimens from YC-1-treated MDA-MB-468 xenografts, EZH2 expression was analysed by Western blotting."1.40YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK. ( Chang, LC; Chou, RH; Hsieh, MT; Huang, LJ; Hung, HY; Kuo, SC; Lee, FY; Lin, HY; Teng, CM; Tsai, MT; Yu, YL, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, LC1
Lin, HY1
Tsai, MT1
Chou, RH1
Lee, FY1
Teng, CM1
Hsieh, MT1
Hung, HY1
Huang, LJ1
Yu, YL1
Kuo, SC1
Harrison, H1
Rogerson, L1
Gregson, HJ1
Brennan, KR1
Clarke, RB1
Landberg, G1

Other Studies

2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Experimental Mammary Neoplasms

ArticleYear
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
    British journal of pharmacology, 2014, Volume: 171, Issue:17

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response R

2014
Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
    Cancer research, 2013, Feb-15, Volume: 73, Issue:4

    Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Estrogen Antagonists;

2013